Skip to main content
RISE logo
Infusion equipment in neonatology

Metrology for Drug Delivery

In healthcare, dosing accuracy of medicines can save lives. Development of new calibration methods for infusion equipment with very low flow rates can assure that the correct amount of medicine over the proper time is delivered to the patient.

Infusion is the most used technology for drug delivery in hospitals today. Because of its widespread application, often in critical situations and by many users, many infusion errors are made. Some of these errors are having severe, potentially life-threatening effects, especially in neonatology. A large percentage of these errors can be avoided if the users of infusion technology have a better understanding of the equipment, but also the accuracy of the infusion equipment is of great importance.

The new Joint Research Project – MeDD II, Metrology for drug delivery, funded under the EMPIR program of the European Commission, involves 15 partners, including 9 National and Designated Metrology Institutes.

The  overall  aim  of  this  project  is  to  improve  dosing  accuracy  and  to  enable  the  traceable  measurement  of volume, flow and pressure in existing drug delivery devices and in-line sensors operating at very low flow rates, down to 5 nL/min. This will be achieved through the development of new calibration methods and by expanding the existing metrological  infrastructure. Consequently, this will improve patient safety.


Project name

Metrology for Drug Delivery



RISE role in project


Project start


42 months

Total budget

ca 2,2 MSEK


IPQ-the Portuguese Institute of Quality


Vinnova, European Commission EMPIR-programme

Project website

Project members

Supports the UN sustainability goals

3. Good health and well-being

Contact person

Oliver Büker


+46 10 516 58 89

Read more about Oliver

Contact Oliver
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.